POSTER SESSION V Wednesday, March 2, 2005   —  9:30 AM - 12:00 Noon Convention Center, Exhibit Hall B GYNECOLOGIC PATHOLOGY 118 The Frequency and Biology of Multiple HPV Infection in Vulvar Neoplasia (954) MH Stoler, M Srodon, GB Baber, RJ Kurman - University of Virginia Health System, Charlottesville, VA; Johns Hopkins Medical Institutions, Baltimore, MD 119 The Distribution of Low and High Risk HPV Types in Vaginal Intraepithelial Neoplasia (VaIN) (952) M Srodon, RJ Kurman, GB Baber, MH Stoler - The Johns Hopkins Medical Institutions, Baltimore, MD; University of Virginia Health System, Charlottesville, VA 120 Expression of CD1a Positive Dendritic Cells and Galectin-3 in Vulvar Squamous Lesions (830) H Brustmann - Thermenklinikum, Moedling/Vienna, Lower Austria, Austria 121 Measurement of Tumor Depth of Invasion Is of Value in Risk Assessment of Vulvar Carcinomas (938) I Rufforny, EJ Wilkinson, NA Massoll - University of Florida, Gainesville, FL 122 Detection of HPV DNA in Metastases from Gynecologic Squamous Cell Carcinomas as an Aid to Diagnosis (839) L Dobbs, L Earls, K Hewan-Lowe - Brody School of Medicine at East Carolina University, Greenville, NC 123 The Weakly Positive Hybrid Capture IIR (HCII) Result for HPV: Correlation with Polymerase Chain Reaction (862) MS Hirsch, L Yuan, CP Crum, JM Federschneider - Brigham & Women's Hospital, Boston, MA 124 Human Papillomavirus Load in Hybrid Capture II Assay: Does Increasing the Cutoff Improve the Test? (920) J Ordi, LM Puig-Tintore, E Sierra, A Torne, R Esteve, M Marginet, M Sole, M Santos, E Campo - IDIBAPS-Hospital Clinic, University of Barcelona, School of Medicine, Barcelona, Spain 125 Human Papillomavirus Testing in the Follow-Up of Women with High-Grade Intraepithelial Lesions after Loop Electrosurgical Excision Procedure (919) J Ordi, LM Puig-Tintoré, A Torné, E Sierra, R Esteve, M Marginet, M SoLé, E Campo - IDIBAPS-Hospital Clínic. University of Barcelona. School of Medicine, Barcelona, Spain 126 Reproducibility of Cervical Biopsy Diagnoses: A Report from the Merck Vaccine Trials (56) MH Stoler, K Liaw, B Ronnett, A Ferenczy, RJ Kurman, B Cai, D Sadow, F Alavrez, E Barr - University of Virginia Health System, Charlottesville, VA; Johns Hopkins Medical Institutions, Baltimore, MD; McGill University, Montreal, QC, Canada; Merck Research Laboratories, Blue Bell, PA 127 Quality Control of Cervical Biopsy Diagnoses: A Report from the Merck Vaccine Trials (955) MH Stoler, K Liaw, B Ronnett, A Ferenczy, RJ Kurman, B Cai, D Sadow, F Alvarez, E Barr - University of Virginia Health System, Charlottesville, VA; Johns Hopkins Medical Institutions, Baltimore, MD; McGill University, Montreal, QC, Canada; Merck Research Laboratories, Blue Bell, PA 128 Low Grade Dysplasia Pap Smears and Negative Cervical Biopsies: Are They Really Non-Correlating Specimens? (827) JP Bissonnette, DC Wilbur - Massachusetts General Hospital, Harvard Medical School, Boston, MA 129 Expression of COX-2, VEGF, Ki-67, and p53, in Squamous Cervical Neoplasia (821) MH Arabi, S Bandyopadhyay, L Fathallah, H Nassar, H Mujtaba, R Ali-Fehmi - Wayne State University, Karmanos Cancer Institute, Detroit, MI 130 Correlation of p16, MCM2, and Cyclin E as Molecular Markers for Cervical Disease in IHC and ICC Formats (928) NK Prpic, M Parker, S Sampson, J Hessling, A Taylor, T Fischer - TriPath Oncology, Durham, NC 131 Proliferative Activity and Biomarker Expressions in Atypical Lobular Endocervical Glandular Hyperplasia (Atypical LEGH) (907) Y Mikami, T Kiyokawa, M Ono, H Sasano - Tohoku University Graduate School of Medical Science, Sendai, Miyagi, Japan; Jikei University Medical School, Minato-ward, Tokyo, Japan 132 Endocervical Adenocarcinoma In Situ (AIS) Confined to the Surface 'Early AIS': Evidence for De Novo Transformation of the Endocervical Surface Mucosa (969) AK Witkiewicz, KR Lee, A Cviko, CP Crum - Brigham and Women's Hospital, Boston, MA 133 Expression of a Novel Carcinoma Antigen (KOC/L523) in Adenocarcinoma In Situ of the Uterine Cervix (889) C Li, Z Jiang, L Kordunsky, K Dresser, K Rock, M Retter, A Fraire - University of Massachusetts Medical School, Worcester, MA; Corixa Corporation, Seattle, WA 134 KOC/L523 Expression Aids in Differential Diagnosis between Endocervical and Endometrial Adenocarcinomas (881) L Kordunsky, B Xu, Z Jiang, B Woda, K Dresser, M Retter, M Vacanti, C Li - University of Massachusetts Medical School, Worcester, MA; Corixa Corporation, Seattle, WA 135 Tenascin: A Possible Marker for Invasive Adenocarcinoma of the Uterine Cervix (897) M Lomme, CJ Sung, MR Quddus, MM Steinhoff, F Liu, WD Lawrence - Women & Infants' Hospital and Brown Medical School, Providence, RI 136 Distinction of Endocervical and Endometrial Adenocarcinomas in Biopsy and Curettage Specimens: Utility of Immunohistochemistry for p16 and Hormone Receptors (910) S Movahedi-Lankarani, BM Ronnett - The Johns Hopkins Hospital, Baltimore, MD 137 Immunohistochemical Stain for p16 Can be Misleading in Distinguishing Endometrial from Endocervical Adenocarcinoma in Small Tissue Samples (879) CS Kong, CB Gilks, TA Longacre - Stanford University School of Medicine, Stanford, CA; Vancouver General Hospital, Vancouver, BC, Canada 138 SNPs in Fas Promoter Region as a Risk Factor of Cervical Squamous Cell Carcinoma (886) E Lerma, M Romero, A Gallardo, Ll Catasus, E Bussaglia, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Spain 139 A Clinicopathologic Study of E-Cadherin and ß-Catenin Expression in Early Stage Cervical Carcinoma Using a Tissue Microarray (848) O Fadare, H Reddy, J Wang, D Hileeto, PE Schwartz, W Zheng - Yale University, New Haven, CT; University of Southern California, Los Angeles, CA; 140 Low D2-40 Immunoreactivity in Cervical Biopsy Material Predicts the Presence of Lymphatic Invasion and Nodal Metastasis (842) KL Dumoff, X Xu, T Pasha, C Chu, PJ Zhang, G Acs - University of Pennsylvania Medical Center, Philadelphia, PA 141 Fatty Acid Synthase (FAS) Expression in Invasive Cervical Carcinomas (870) H Ji, CY Hsu, BM Ronnett, TC Wu, FP Kuhajda - The Johns Hopkins Medical Institutions, Baltimore, MD 142 The Clinical Significance of CD9/Motility Related Protein-1(MRP-1) in Invasive Squamous Cell Carcinoma of the Uterine Cervix: A Tissue Microarray Study (902) H Masoudi, BC Gilks, D Huntsman, E Yorida, LC Horn, DJ Van Niekerk - University of BC, Vancouver, BC, Canada; Vancouver General Hospital and University of BC, Vancouver, BC, Canada; University of Leipzig, Leipzig, Germany 143 Ethnic Differences in Expression of Nuclear Receptors and Co-Factors in Uterine Leiomyomata (968) JJ Wei, L Chiriboga, AA Arslan, J Melamed, H Yee, K Mittal - New York University, New York, NY 144 Expression Profile of the Tumorigenic Factors in Association with Tumor Size and Sex Steroid Hormone Status in Uterine Leiomyomata (967) JJ Wei, L Chiriboga, K Mittal - New York University, New York, NY 145 Large Uterine Leiomyomata: Spatial Distribution of the Tumorigenic Factors (974) XM Zhang, K Mittal, L Chiriboba, H Yee, JJ Wei - New York University School of Medicine, New York, NY 146 A Comparison of the Performance of Smooth Muscle Myosin Heavy Chain (SMMS-1) Versus Caldesmon, Desmin, and Smooth Muscle Actin in the Evaluation of Uterine Smooth Muscle Tumors (899) A Malpica, J Averyt, MT Deavers, E Euscher, EG Silva - The University of Texas M.D. Anderson Cancer Center, Houston, TX; The Methodist Hospital, San Antonio, TX 147 Use of Histone Deacetylase 8 (HDAC8), a New Marker of Smooth Muscle Differentiation, in the Subclassification of Mesenchymal Tumors of the Uterus, Particularly Epithelioid Smooth Muscle Tumors (837) L de Leval, D Waltregny, W Glenisson, J Boniver, RH Young, V Castronovo, E Oliva - CHU Sart-Tilman, Liege, Belgium; Center for Experimental Cancer Research, Liege, Belgium; Massachusetts General Hospital, Boston, MA 148 Uterine Cellular Leiomyomata: Molecular Resemblance to the Usual Type Leiomyomata (854) HG Gao, K Mittal, L Chiriboba, H Yee, JJ Wei - New York University, New York, NY 149 Benign Metastasizing Leiomyoma Is Clonally Derived from Uterine Leiomyoma (923) KT Patton, V Papavero, L Chiang, A Yeldandi, P Hui, XJ Yang - Feinberg School of Medicine, Northwestern University, Chicago, IL; Indiana University Medical Center, Indianapolis, IN; Yale University School of Medicine, New Haven, CT 150 Areas of Leiomyoma Associated with Some Uterine Leiomyosarcomas (871) A Joutovsky, K Mittal - NYU School of Medicine, New York, NY 151 Up Regulation of Retinoid Acid Receptor X (RXRa) in Uterine Leiomyosarcomas (976) H Zhu, K Mittal, J Melamed, S Goswami, L Chiriboba, JJ Wei - New York University School of Medicine, New York, NY 152 Expression of Multidrug Resistance-Related Proteins P-gp, MRP1, and LRP in Uterine Sarcomas (971) E Yakirevich, I Naroditsky, E Sabo, O Lavie, Y Sova, MB Resnick - Carmel Medical Center, Haifa, Israel; Rhode Island Hospital, Providence, RI 153 Immunohistochemical Evaluation of the c-kit Proto-Oncogene Expression in Sarcomas of the Gynecologic Region (913) M Nakayama, T Mitsuhashi, Y Shimizu, S Ban, F Ogawa, T Hirose, O Ishihara, M Shimizu - Saitama Medical School, Iruma-gun, Saitama, Japan 154 Endometrial Stromal Sarcoma - Observational Evidence of a Genetic Background? (930) S Regauer, O Reich - Medical University of Graz, Graz, Austria; Medical University of Graz, Graz, Austria 155 Gonadotropin-Releasing Hormone Receptor Expression in Endometrial Stromal Sarcomas (931) O Reich, FF Nogales, S Regauer - Medical University of Graz, Graz, Austria; University of Granada, Granada, Spain 156 Uterine Tumors Resembling Ovarian Sex Cord Tumors Are Polyphenotypic Neoplasms with True Sex Cord Differentiation (867) JA Irving, S Carinelli, M Arguelles, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Spain; Istituti Clinici di Perfezionamento, Milano, Italy 157 Uterus-Like Masses (Endomyometriosis): Clinico-Pathologic Profile of 5 Cases (898) RK Malhotra, W Slater, SH Merchant, EG Silva, MB Amin - William Beaumont Hospital, Royal Oak, MI; Wayne State University, Detroit, MI; University of New Mexico, Albuquerque, NM; The University of Texas, M D Anderson Cancer Center, Houston, TX